Morgan Stanley's Wilson Finally Turns More Positive, Sees Stocks Rallying in Near Term
- Wall Street rises after encouraging inflation data with Fed on deck
- ExxonMobil gains following record profit, 'solid execution'
- Caterpillar Q4 earnings miss as costs weigh
- U.S. labor cost growth smallest in a year; labor persistently tight
- Tesla updates risks to include Musk selling stock to satisfy other commitments
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
Mike Wilson, the Chief U.S. Equity Strategist and Chief Investment Officer for Morgan Stanley, argues that the selling pressure on U.S. equities may finally ease, at least in the near term.
While the U.S. witnessed another red-hot CPI report last week, Wilson argues that this type of data is “some of the most backward-looking economic series and tell us little about the future.”
“In our view, inflation has already peaked and could fall rapidly next year as comparisons become very difficult and discounting returns. This would argue for lower back end rates, which could be supportive for stocks until the earnings are cut as we expect and/or a full blown recession arrives,” Wilson said in a client note.
Wilson sees technicals gaining an upper hand on fundamentals. Along these lines, one of the most bearish strategists on the Street in 2022 sees the case building for a “tradable tactical rally.”
Among other factors, Wilson also noted that history shows earnings recessions are slow to play out.
“While it feels like this downward EPS revision cycle has been in process for a long time, we're only about 3 months in from the early July peak in numbers… It typically takes time for bottom-up consensus expectations to reflect the top-down earnings risk,” Wilson added.
Finally, the strategist reiterated his “constructive view” on the Healthcare sector going into the year-end.
By Senad Karaahmetovic
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pfizer falls as slowing demand for COVID-19 drugs weighs on outlook
- C3.ai (AI) surges on launch of AI Product Suite - Wolfe Research questions details
- Victoria’s Secret (VCSO) trades up on ASR agreement and 4Q update
Create E-mail Alert Related CategoriesAnalyst Comments, Hot Comments, Hot List, Trader Talk
Related EntitiesMorgan Stanley, Earnings, Senad Karaahmetovic
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!